About this FactMed analysis covering adverse side effect reports of GLUCAGON patients who developed THERAPY NON-RESPONDER.

FactMed provides MD-approved analysis to help both patients, researchers, and physicians accurately assess the risk profile for more than 20,000 different pharmaceutical products. The below report offers compiled information from Food & Drug Administration and FactMed user submissions. Between January 2004 and October 2012, 1 individuals taking GLUCAGON reported THERAPY NON-RESPONDER to the FDA. A total of 494 GLUCAGON drug adverse event reaction reports were made with the FDA during this time period. Often the FDA only receives reports of the most critical and severe cases; these numbers may therefore underrepresent the complication rate of the medication.

FDA Research Report

Introduction This page is designed to help you determine the relationship, if any, between GLUCAGON and THERAPY NON-RESPONDER. In doing so, we compare GLUCAGON with other drugs that cause THERAPY NON-RESPONDER, to help you evaluate whether or not GLUCAGON causes THERAPY NON-RESPONDER. Likewise, this page shows the most highly-reported side effects of GLUCAGON, so you can see if THERAPY NON-RESPONDER ranks among GLUCAGON's most well-known side effects.
Summary Statistics
Reports of GLUCAGON causing THERAPY NON-RESPONDER: 1
Reports of any side effect of GLUCAGON : 494
Percentage of GLUCAGON patients where THERAPY NON-RESPONDER is a reported side effect: 0.2024%

FDA reports of any drug causing THERAPY NON-RESPONDER : 3953
Average percentage for all medicated patients where THERAPY NON-RESPONDER is reported as a complication: 0.0248%

Physician opinion on GLUCAGON as adverse event culprit:

Overall opinion for all reports of this drug:
Most frequent diagnoses/indications for prescribing GLUCAGON:
PRODUCT USED FOR UNKNOWN INDICATION ( 44 patients )
HYPOGLYCAEMIA ( 33 patients )
DRUG USE FOR UNKNOWN INDICATION ( 20 patients )
DIABETES MELLITUS ( 11 patients )
TYPE 2 DIABETES MELLITUS ( 10 patients )
BLOOD GLUCOSE DECREASED ( 9 patients )
GASTROINTESTINAL ENDOSCOPIC THERAPY ( 8 patients )
DIAGNOSTIC PROCEDURE ( 8 patients )
INTESTINAL POLYPECTOMY ( 7 patients )
HYPERGLYCAEMIA ( 6 patients )
GLUCAGON TOLERANCE TEST ( 5 patients )
COLONOSCOPY ( 4 patients )
ENDOSCOPY UPPER GASTROINTESTINAL TRACT ( 4 patients )
ENDOSCOPY ( 3 patients )
ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY ( 3 patients )
ENDOSCOPY GASTROINTESTINAL ( 3 patients )
HYPOGLYCAEMIA NEONATAL ( 2 patients )
HYPOGLYCAEMIC UNCONSCIOUSNESS ( 2 patients )
HEPATITIS FULMINANT ( 2 patients )
CONVULSION ( 2 patients )
DIABETES MELLITUS INSULIN-DEPENDENT ( 2 patients )
GASTRIC CANCER ( 2 patients )
RESUSCITATION ( 1 patients )
BLOOD GLUCOSE INCREASED ( 1 patients )
DIABETIC COMA ( 1 patients )
LOSS OF CONSCIOUSNESS ( 1 patients )
GASTROINTESTINAL DISORDER ( 1 patients )
SHOCK HYPOGLYCAEMIC ( 1 patients )
GASTROINTESTINAL OBSTRUCTION ( 1 patients )
CARDIOGENIC SHOCK ( 1 patients )
X-RAY ( 1 patients )
HYPOGLYCAEMIC SEIZURE ( 1 patients )
HYPOTENSION ( 1 patients )
JAUNDICE ( 1 patients )
OESOPHAGEAL FOOD IMPACTION ( 1 patients )
( 0 patients )
Drugs with high FDA adverse event association with THERAPY NON-RESPONDER:

ASPIRIN (270 patients)
VIOXX (237 patients)
REMICADE (177 patients)
METHOTREXATE (173 patients)
ACCUTANE (150 patients)
PREDNISONE (148 patients)
LIPITOR (146 patients)
PREDNISOLONE (128 patients)
CYCLOPHOSPHAMIDE (126 patients)
FUROSEMIDE (122 patients)
LASIX (113 patients)
ATENOLOL (101 patients)
NEURONTIN (101 patients)
ACETAMINOPHEN (96 patients)
PEGASYS (95 patients)
CELEBREX (91 patients)
NORVASC (90 patients)
LISINOPRIL (89 patients)
AVONEX (86 patients)
OMEPRAZOLE (86 patients)
FOLIC ACID (85 patients)
CYCLOSPORINE (80 patients)
SYNTHROID (78 patients)
COPEGUS (78 patients)
DEXAMETHASONE (77 patients)
ALBUTEROL (71 patients)
ALLOPURINOL (70 patients)
IBUPROFEN (64 patients)
OXYCONTIN (64 patients)
PREDNISONE TAB (63 patients)
LEVOTHYROXINE SODIUM (63 patients)
CYTARABINE (61 patients)
LEXAPRO (59 patients)
DIGOXIN (58 patients)
PROTONIX (58 patients)
PLAVIX (57 patients)
LANSOPRAZOLE (57 patients)
SOLU-MEDROL (56 patients)
METHYLPREDNISOLONE (56 patients)
ARANESP (56 patients)
HYDROCHLOROTHIAZIDE (55 patients)
ZOLOFT (55 patients)
MORPHINE (54 patients)
VELCADE (54 patients)
PROGRAF (54 patients)
CANCIDAS (54 patients)
XANAX (53 patients)
PAXIL (52 patients)
PREVACID (52 patients)
VINCRISTINE (51 patients)
DECADRON (50 patients)
VANCOMYCIN (50 patients)
COUMADIN (50 patients)
BEXTRA (49 patients)
PRILOSEC (49 patients)
ATORVASTATIN CALCIUM (48 patients)
LORAZEPAM (48 patients)
PROZAC (48 patients)
ZOCOR (47 patients)
ACYCLOVIR (47 patients)
SIMVASTATIN (47 patients)
VICODIN (47 patients)
NEXIUM (46 patients)
ZYPREXA (45 patients)
WARFARIN SODIUM (45 patients)
ATIVAN (44 patients)
FLUOROURACIL (44 patients)
TOPROL-XL (43 patients)
GEMZAR (43 patients)
RIBAVIRIN (43 patients)
CLONAZEPAM (42 patients)
TEGRETOL (42 patients)
PEG-INTRON (41 patients)
AMBIEN (41 patients)
EFFEXOR (40 patients)
LAMIVUDINE (40 patients)
VIAGRA (40 patients)
FORTEO (39 patients)
FENTANYL (39 patients)
FLUCONAZOLE (39 patients)
GLEEVEC (39 patients)
PREMARIN (38 patients)
DOXORUBICIN HCL (38 patients)
TRAZODONE HCL (37 patients)
NITROGLYCERIN (37 patients)
HEPARIN (37 patients)
AZATHIOPRINE (36 patients)
LEVAQUIN (36 patients)
FOSAMAX (36 patients)
OXYCODONE HCL (36 patients)
INSULIN (36 patients)
PROPOFOL (36 patients)
RANITIDINE (35 patients)
CLOFARABINE (34 patients)
REBETOL (34 patients)
HUMALOG (34 patients)
AMITRIPTYLINE HCL (33 patients)
NEUPOGEN (33 patients)
ENALAPRIL MALEATE (33 patients)
CISPLATIN (33 patients)
DIAZEPAM (33 patients)
AVASTIN (33 patients)
ALL OTHER THERAPEUTIC PRODUCTS (ALL OTHER THERAPEUTIC PRODUCTS) (33 patients)
ALPRAZOLAM (33 patients)
WELLBUTRIN (32 patients)
ETOPOSIDE (32 patients)
BENADRYL (32 patients)
HYDROCORTISONE (32 patients)
METOPROLOL (31 patients)
DURAGESIC-100 (31 patients)
PERCOCET (31 patients)
VALIUM (31 patients)
CIPROFLOXACIN (31 patients)
ZANTAC (31 patients)
SPIRONOLACTONE (31 patients)
ATROVENT (31 patients)
CARBOPLATIN (31 patients)
FAMOTIDINE (30 patients)
MORPHINE SULFATE (30 patients)
FLONASE (30 patients)
CELLCEPT (30 patients)
ZYRTEC (30 patients)
VERAPAMIL (30 patients)
SEROQUEL (30 patients)
TRAMADOL HCL (30 patients)
AMLODIPINE (30 patients)
ACTOS (29 patients)
NIFEDIPINE (29 patients)
THALOMID (29 patients)
GABAPENTIN (28 patients)
ENBREL (28 patients)
ZOFRAN (28 patients)
BACTRIM (28 patients)
GLYBURIDE (28 patients)
LITHIUM CARBONATE (28 patients)
BACLOFEN (27 patients)
MIRTAZAPINE (27 patients)
TAXOTERE (27 patients)
ACETYLSALICYLIC ACID SRT (27 patients)
INTRON A (27 patients)
TYLENOL (27 patients)
FLUOXETINE (27 patients)
DIFLUCAN (27 patients)
ADVAIR DISKUS 100/50 (27 patients)
MYCOPHENOLATE MOFETIL (27 patients)
MULTI-VITAMINS (27 patients)
MAGNESIUM OXIDE (26 patients)
CLONIDINE (26 patients)
METOPROLOL TARTRATE (26 patients)
MULTI-VITAMIN (26 patients)
METOCLOPRAMIDE (26 patients)
DILTIAZEM (26 patients)
AMOXICILLIN (26 patients)
CARBAMAZEPINE (25 patients)
LYRICA (25 patients)
VOLTAREN (25 patients)
CLARITIN (25 patients)
CLOPIDOGREL (25 patients)
IRESSA (25 patients)
KEPPRA (25 patients)
RISPERDAL (25 patients)
POTASSIUM CHLORIDE (25 patients)
AMARYL (25 patients)
GLUCOPHAGE (25 patients)
SINGULAIR (25 patients)
AMPHOTERICIN B (25 patients)
ALDACTONE (25 patients)
PLACEBO (24 patients)
PANTOPRAZOLE SODIUM (24 patients)
DIOVAN (24 patients)
BOTOX (23 patients)
DETROL LA (23 patients)
METFORMIN HCL (23 patients)
CELEXA (23 patients)
ZOMETA (23 patients)
LEVOFLOXACIN (23 patients)
PROCRIT (23 patients)
CAPTOPRIL (23 patients)
TYLENOL (CAPLET) (22 patients)
AZITHROMYCIN (22 patients)
BETASERON (22 patients)
RAPAMUNE (22 patients)
ITRACONAZOLE (22 patients)
VITAMIN E (22 patients)
CLARITHROMYCIN (21 patients)
DEXAMETHASONE TAB (21 patients)
TOPAMAX (21 patients)
DIDANOSINE (21 patients)
ZITHROMAX (21 patients)
LANTUS (21 patients)
STAVUDINE (21 patients)
LORTAB (21 patients)
K-DUR 10 (21 patients)
VIREAD (21 patients)
ZIDOVUDINE (21 patients)
LAMICTAL (21 patients)
ISOSORBIDE MONONITRATE (21 patients)
INDOCIN I.V. (21 patients)
CALCIUM GLUCONATE (21 patients)
VORICONAZOLE (21 patients)
DAUNORUBICIN HCL (20 patients)
SEREVENT (20 patients)
LOVENOX (20 patients)
ZOLPIDEM TARTRATE (20 patients)
FLOVENT (20 patients)
ZETIA (20 patients)
METRONIDAZOLE (20 patients)
VFEND (20 patients)
PREDONINE (20 patients)
CIPRO (20 patients)
Most common side effects for patients taking GLUCAGON:
HYPOTENSION (59 patients)
DYSPNOEA (58 patients)
NAUSEA (58 patients)
VOMITING (53 patients)
PNEUMONIA (49 patients)
ASTHENIA (45 patients)
RENAL FAILURE (44 patients)
BLOOD GLUCOSE INCREASED (44 patients)
DIZZINESS (43 patients)
PAIN (42 patients)
DEHYDRATION (40 patients)
HYPOAESTHESIA (39 patients)
HYPOGLYCAEMIA (39 patients)
ANAEMIA (38 patients)
RENAL FAILURE ACUTE (38 patients)
FATIGUE (37 patients)
BLOOD GLUCOSE DECREASED (37 patients)
ANXIETY (36 patients)
LOSS OF CONSCIOUSNESS (31 patients)
ABDOMINAL PAIN (30 patients)
CHEST PAIN (29 patients)
PAIN IN EXTREMITY (28 patients)
DIARRHOEA (28 patients)
GENERAL PHYSICAL HEALTH DETERIORATION (28 patients)
ATRIAL FIBRILLATION (27 patients)
CARDIAC FAILURE CONGESTIVE (27 patients)
URINARY TRACT INFECTION (26 patients)
HYPOXIA (26 patients)
DEEP VEIN THROMBOSIS (26 patients)
SEPSIS (25 patients)
PULMONARY OEDEMA (24 patients)
RESPIRATORY FAILURE (23 patients)
CONVULSION (23 patients)
HYPERTENSION (21 patients)
MENTAL STATUS CHANGES (21 patients)
DIABETES MELLITUS (21 patients)
DEPRESSED LEVEL OF CONSCIOUSNESS (20 patients)
BACK PAIN (20 patients)
PLEURAL EFFUSION (20 patients)
CELLULITIS (20 patients)
DRUG INEFFECTIVE (20 patients)
SPINAL COLUMN STENOSIS (19 patients)
ARRHYTHMIA (19 patients)
NEUROPATHY PERIPHERAL (19 patients)
THROMBOCYTOPENIA (19 patients)
BRADYCARDIA (19 patients)
COUGH (19 patients)
OEDEMA PERIPHERAL (19 patients)
CARDIOGENIC SHOCK (19 patients)
INJURY (18 patients)
FALL (18 patients)
CONFUSIONAL STATE (18 patients)
ARTHRALGIA (18 patients)
BONE DISORDER (18 patients)
HYPERHIDROSIS (18 patients)
CHOLELITHIASIS (18 patients)
HYPOMAGNESAEMIA (18 patients)
PARAESTHESIA (17 patients)
HEPATIC FAILURE (17 patients)
INFECTION (17 patients)
HAEMORRHOIDS (17 patients)
PULMONARY EMBOLISM (17 patients)
ASTHMA (17 patients)
MYOCARDIAL INFARCTION (17 patients)
WEIGHT DECREASED (17 patients)
GASTROINTESTINAL HAEMORRHAGE (17 patients)
CHRONIC OBSTRUCTIVE PULMONARY DISEASE (17 patients)
DYSPHAGIA (16 patients)
PYREXIA (16 patients)
SWELLING (16 patients)
BLOOD PRESSURE DECREASED (16 patients)
OSTEONECROSIS OF JAW (16 patients)
MALAISE (16 patients)
PHARMACEUTICAL PRODUCT COMPLAINT (16 patients)
VENTRICULAR TACHYCARDIA (15 patients)
HEADACHE (15 patients)
HYPERKALAEMIA (15 patients)
AZOTAEMIA (15 patients)
SEPTIC SHOCK (15 patients)
ELECTROLYTE IMBALANCE (15 patients)
OBESITY (15 patients)
LOOSE TOOTH (15 patients)
SCOLIOSIS (14 patients)
TRANSFUSION (14 patients)
RESPIRATORY DISTRESS (14 patients)
LIVER DISORDER (14 patients)
PAIN IN JAW (14 patients)
GAIT DISTURBANCE (14 patients)
MULTI-ORGAN FAILURE (14 patients)
TOOTH EXTRACTION (14 patients)
TOOTH LOSS (14 patients)
TREMOR (14 patients)
DECREASED APPETITE (14 patients)
DECREASED INTEREST (14 patients)
HYPERGLYCAEMIA (14 patients)
HIATUS HERNIA (13 patients)
ROTATOR CUFF SYNDROME (13 patients)
INSOMNIA (13 patients)
OSTEOLYSIS (13 patients)
MUSCULOSKELETAL PAIN (13 patients)
HAEMOLYSIS (13 patients)
ANAEMIA OF CHRONIC DISEASE (13 patients)
HYPONATRAEMIA (13 patients)
INTERMITTENT CLAUDICATION (13 patients)
CONSTIPATION (13 patients)
ARTHROPATHY (13 patients)
GASTRITIS (13 patients)
ECONOMIC PROBLEM (13 patients)
INTERVERTEBRAL DISC PROTRUSION (13 patients)
PULMONARY HYPERTENSION (13 patients)
RENAL CYST (13 patients)
RENAL MASS (13 patients)
DENTAL CARIES (13 patients)
SENSORY LOSS (13 patients)
CATARACT (13 patients)
SCIATICA (13 patients)
ORAL INFECTION (13 patients)
SPINAL OSTEOARTHRITIS (13 patients)
PLATELET COUNT DECREASED (13 patients)
COMA (12 patients)
OSTEOMYELITIS (12 patients)
MEDICATION ERROR (12 patients)
GINGIVAL BLEEDING (12 patients)
VISION BLURRED (12 patients)
CARDIAC ARREST (12 patients)
SLEEP DISORDER (12 patients)
HAEMANGIOMA (12 patients)
ANHEDONIA (11 patients)
TENDONITIS (11 patients)
EXOSTOSIS (11 patients)
ATELECTASIS (11 patients)
METABOLIC ACIDOSIS (11 patients)
SPEECH DISORDER (11 patients)
PUBIS FRACTURE (11 patients)
HEART RATE INCREASED (11 patients)
BURSITIS (11 patients)
OSTEONECROSIS (11 patients)
CARDIOMEGALY (11 patients)
JAW DISORDER (10 patients)
ENCEPHALOPATHY (10 patients)
INTERVERTEBRAL DISC DEGENERATION (10 patients)
PATHOLOGICAL FRACTURE (10 patients)
HAEMATEMESIS (10 patients)
SOFT TISSUE DISORDER (10 patients)
HAEMATOMA (10 patients)
DEATH (10 patients)
DEPRESSION (10 patients)
SKIN ULCER (10 patients)
DIVERTICULITIS (10 patients)
CEREBROVASCULAR ACCIDENT (10 patients)
DYSGEUSIA (10 patients)
ABDOMINAL DISTENSION (9 patients)
SYNCOPE (9 patients)
SWELLING FACE (9 patients)
HYPOGLYCAEMIC UNCONSCIOUSNESS (9 patients)
TOOTHACHE (9 patients)
INCORRECT DOSE ADMINISTERED (9 patients)
NECK PAIN (9 patients)
HAEMODIALYSIS (9 patients)
TENDERNESS (9 patients)
INTERNATIONAL NORMALISED RATIO INCREASED (9 patients)
HYPOGLYCAEMIC COMA (9 patients)
ENDOTRACHEAL INTUBATION (9 patients)
BONE LESION (9 patients)
CORONARY ARTERY DISEASE (9 patients)
BREAKTHROUGH PAIN (9 patients)
RENAL FAILURE CHRONIC (9 patients)
EXPOSED BONE IN JAW (9 patients)
OVERDOSE (9 patients)
CARDIAC OUTPUT DECREASED (9 patients)
FISTULA (9 patients)
CARDIO-RESPIRATORY ARREST (9 patients)
CEREBELLAR ISCHAEMIA (9 patients)
GINGIVITIS (9 patients)
MULTIPLE INJURIES (9 patients)
EPILEPSY (8 patients)
HIP FRACTURE (8 patients)
PAROTID GLAND ENLARGEMENT (8 patients)
HALLUCINATION, VISUAL (8 patients)
LOCAL SWELLING (8 patients)
ATROPHY (8 patients)
PANCREATITIS (8 patients)
HYPOKALAEMIA (8 patients)
STAPHYLOCOCCAL BACTERAEMIA (8 patients)
SOMNOLENCE (8 patients)
BONE OPERATION (8 patients)
TRICUSPID VALVE INCOMPETENCE (8 patients)
DEBRIDEMENT (8 patients)
NEPHROGENIC SYSTEMIC FIBROSIS (8 patients)
DIABETIC NEUROPATHY (8 patients)
SERRATIA BACTERAEMIA (8 patients)
CENTRAL VENOUS CATHETERISATION (8 patients)
CHILLS (8 patients)
HYPOGLYCAEMIC SEIZURE (8 patients)
SUICIDAL IDEATION (8 patients)
SYSTEMIC INFLAMMATORY RESPONSE SYNDROME (8 patients)
PRURITUS GENERALISED (8 patients)
DYSPEPSIA (8 patients)
GASTROOESOPHAGEAL REFLUX DISEASE (7 patients)
AGGRESSION (7 patients)
AGITATION (7 patients)
EMOTIONAL DISORDER (7 patients)
PNEUMONIA KLEBSIELLA (7 patients)
BALANCE DISORDER (7 patients)
MOBILITY DECREASED (7 patients)
DISSEMINATED INTRAVASCULAR COAGULATION (7 patients)
CEREBRAL ATROPHY (7 patients)
GASTRIC ULCER (7 patients)
HYPOVOLAEMIA (7 patients)
HYPOPHAGIA (7 patients)

In addition to reviewing our up-to-date FDA research, users may interact with the FactMed community - currently one million members and growing! FactMed online research and discussions are read by patients, scientists, physicians, and other interested health care parties. Post follow up Questions to learn from our diverse readership. Likewise, patients who have experienced unwanted effects are encouraged to share their Concerns to help educate and inform our members.


Recent FactMed Activity for GLUCAGON


Issue Description / Topic Timestamp

My Patient Resources

Get your questions answered! Over one million patients, researchers, and health care providers have visited FactMed. If you have a question about THERAPY NON-RESPONDER and GLUCAGON, post it here. You may receive a response from a fellow patient - or a leading expert in the field.
Your Question:

Share your experience: Over one million patients, researchers, and health care providers have visited FactMed. If you have a noteworthy experience as a patient taking GLUCAGON, post it here. Your story could help a fellow patient - or provide insight to a leading expert in the field.
Your Experience or Concern:

Telemedicine Expert Consults FactMed newest feature allows patients to consult - via realtime videoconferencing - experts in GLUCAGON. This premium feature connects patients to experts, regardless of geography. FactMed experts charge reasonable rates that may be reimbursable by your insurance as a second-opinion.
We are currently accepting registration for GLUCAGON experts. If you are a healthcare provider experienced in prescribing GLUCAGON, please register here.
© 2014 FactMed, Inc
Privacy Policy
Terms of Use